Answers are grounded in this paper and cite their sources.
Experimental study demonstrates photoinduced palladium-catalyzed cross-coupling of chloroacetamides, highlighting a versatile pathway to functional pharmaceuticals.
A visible light-induced palladium catalyzed intramolecular and intermolecular C(sp3)–C(sp2) cross-coupling reaction has been established. This synthetic method exhibits broad functional group tolerance and a wide substrate scope including bioactive molecules, pharmaceutical scaffolds, and peptides, enabling access to structurally novel β,γ-unsaturated amides, benzazepine derivatives as bioisosteres of sedative–hypnotic 1,4-benzodiazepine drugs, and heterocyclic acetamides. Moreover, it offers a direct route to commercially relevant pharmaceuticals such as zolpidem and alpidem. Notably, the successful synthesis of key inhibitors─including those targeting KDM5B, JNK1, and PDE10A─highlights the practical significance and broad applicability of this method. The reaction mechanism was explored using control experiments, Stern–Volmer fluorescence quenching experiments, light on/off experiments, and density functional theory (DFT) calculations.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: